• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
    • Español (Spanish)
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Shopping Cart
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

Guselkumab (Tremfya®)

January 1, 2021

This sheet is about exposure to guselkumab in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider.

What is guselkumab?

Guselkumab is a medication used to treat adults with moderate to severe plaque psoriasis and psoriatic arthritis. It is taken by an injection under the skin and is sold under the brand name Tremfya®. For more information about psoriasis, please see the MotherToBaby fact sheet on psoriasis in pregnancy at https://mothertobaby.org/fact-sheets/psoriasis-and-pregnancy/.

I take guselkumab. Can it make it harder for me to get pregnant?

It is not known if guselkumab can make it harder to become pregnant.

I just found out I am pregnant. Should I stop taking guselkumab?

Talk with your healthcare providers before making any changes to how you take your medication(s). They can go over your options, weighing the risks and benefits of treating or not treating your condition.

How long does guselkumab stay in my body?

People eliminate medications from their bodies at different rates. Guselkumab can remain in the body for up to three months after the last dose.

Does taking guselkumab increase the chance for miscarriage? 

Miscarriage can occur in any pregnancy. It is not known if guselkumab increases the chance for miscarriage.

Does taking guselkumab increase the chance of birth defects?

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Based on the available data, it is not known if taking guselkumab increases the chance of birth defects. Because guselkumab is an antibody, transfer of the medication to the developing baby might be low in early pregnancy, when many of the organs are forming.

Could taking guselkumab cause other pregnancy complications?

It is not known if guselkumab can cause other pregnancy complications.

Does taking guselkumab in pregnancy cause long-term problems in behavior or learning for the baby? 

It is not known if guselkumab can cause behavior or learning issues.

Can I breastfeed while taking guselkumab?

Guselkumab has not been well-studied in breastfeeding. It is a very large protein, so not very much is expected to pass into breast milk. Guselkumab is not well absorbed from the gut, so any medication that gets into breast milk would be unlikely to enter the baby’s system. Babies born before 37 weeks of pregnancy (preterm delivery) and newborns have digestive systems that are not fully developed, which could allow more of the medication to be absorbed from the breast milk. Be sure to talk to your healthcare provider about all of your breastfeeding questions. 

I take guselkumab. Can it make it harder for me to get my partner pregnant or increase the chance of birth defects? 

It is not known if there are possible risks to a pregnancy when a father or sperm donor takes guselkumab. In general, exposures that fathers and sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/pdf/.

MotherToBaby is currently conducting a study looking at guselkumab and other medications used to treat psoriasis in pregnancy. If you are interested in taking part in this study, please call 1-877-311-8972 or or sign up at https://mothertobaby.org/join-study/.

Please click here for references.

OTIS/MotherToBaby recognizes that not all people identify as “men” or “women.” When using the term “mother,” we mean the source of the egg and/or uterus and by “father,” we mean the source of the sperm, regardless of the person’s gender identity.

View PDF Fact Sheet

Related Baby Blogs

  • Empowering Moms this Mother’s Day and Every Day: Making the Most of Prenatal Appointments
  • Flare-ups Fueling Fears During Pregnancy? Stop In The Name Of Psoriasis!
  • ‘Benefiting Other Moms Like Me:’ Why One Mom Chose Research Over Fear

Related Studies

  • Cimzia® (certolizumab pegol)
  • Ilumya™ (tildrakizumab-asmn)
  • Otezla® (apremilast)
  • Psoriasis
  • Psoriatic Arthritis
  • Tremfya® (guselkumab)

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whooping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2022 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^